AKT1 and metabolic dysfunction-associated steatotic liver disease: Besides the TGF/SMAD pathway, the phosphoinositide 3-kinase/protein kinase C/forkhead box protein O1 (PI3K/Akt/FoxO1) pathway is also a key modulator for liver fibrosis in NAFLD [140].